ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 928,19
-0,71%
Dow Jones
37 903,29
0,00%
DAX
17 937,81
0,09%
Brent Oil
84,195
0,78%
Bitcoin
58 973,98
1,26%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BioCryst Pharmaceuticals Inc (BCRX)

  7. BioCryst Pharmaceuticals Inc (BCRX) Actualités

BCRX BioCryst Pharmaceuticals Inc

4,59
0,02 (0,44%)
Avant marché
Dernière mise à jour : 13:58:27
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
BioCryst Pharmaceuticals Inc BCRX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,02 0,44% 4,59 13:58:27
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,57
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
22/4/202413:00GLOBEBioCryst to Report First Quarter 2024 Financial Results on..
17/4/202410:30GLOBEBioCryst Announces Approval of ORLADEYO® (berotralstat) by..
03/4/202413:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
25/3/202421:01GLOBEBioCryst to Present at Upcoming Investor Conferences
05/3/202413:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
04/3/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
26/2/202413:05EDGAR2Form 8-K - Current report
26/2/202413:00GLOBEBioCryst Reports Fourth Quarter and Full Year 2023 Financial..
26/2/202411:57IHMARKETNEWSU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil..
23/2/202413:00GLOBEBioCryst Presents New Real-world Data Showing Rapid,..
21/2/202422:01GLOBEBioCryst to Present at Upcoming Investor Conferences
19/2/202413:54GLOBEBioCryst Launches ORLADEYO® (berotralstat) in Italy
14/2/202422:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/2/202413:00GLOBEBioCryst to Report Fourth Quarter 2023 Financial Results on..
05/2/202413:00GLOBEBioCryst to Present New ORLADEYO® (berotralstat) Real-world..
02/2/202413:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
24/1/202423:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/1/202423:21EDGAR2Form 8-K - Current report
08/1/202413:02EDGAR2Form 8-K - Current report
05/1/202422:01GLOBEBioCryst Announces Preliminary Full Year 2023 ORLADEYO®..
04/1/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
03/1/202413:00GLOBEBioCryst to Present at 42nd Annual J.P. Morgan Healthcare..
20/12/202322:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202313:00GLOBEBioCryst Announces Publication of Data from Open-label..
18/12/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
01/12/202322:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202313:37EDGAR2Form 8-K - Current report
30/11/202315:04EDGAR2Form 8-K - Current report
29/11/202313:00GLOBEBioCryst Announces Approval of ORLADEYO® (berotralstat) by..
21/11/202322:01GLOBEBioCryst to Present at Upcoming Investor Conferences
21/11/202313:00GLOBEBioCryst Launches ORLADEYO® (berotralstat) in Spain
10/11/202313:00GLOBEBioCryst Presents New Real-world Data Showing Reduced Attack..
08/11/202322:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/11/202322:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202322:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
03/11/202317:16EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
BCRX
BioCryst Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés